Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-16-016629
Filing Date
2016-09-08
Accepted
2016-09-08 16:08:41
Documents
1
Period of Report
2016-08-30

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f3083016friedman_oramed.html 3  
1 OWNERSHIP DOCUMENT f3083016friedman_oramed.xml 3 4166
  Complete submission text file 0001213900-16-016629.txt   5767
Mailing Address HI-TECH PARK 2/4 GIVAT-RAM PO BOX 39098 JERUSALEM L3 91390
Business Address HI-TECH PARK 2/4 GIVAT-RAM PO BOX 39098 JERUSALEM L3 91390 011 972-2-566-0001
ORAMED PHARMACEUTICALS INC. (Issuer) CIK: 0001176309 (see all company filings)

EIN.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations

Mailing Address HADASSA 6 TEL AVIV L3 6451306
Business Address
Friedman Aviad (Reporting) CIK: 0001683729 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35813 | Film No.: 161876258